Northwestern memorial hospital
Chicago, Illinois 97232
89 studies enrolling now · 542 studies all time
What they study most
AML, AML, Adult, ARDS, Abdominal Aortic Aneurysms, Achalasia, Actinic Keratosis, Active Idiopathic Inflammatory Myopathy, Acute Alcoholic Hepatitis, Acute Antibody-Mediated Rejection (AMR), Acute Blood Loss, Acute Coronary Syndrome (ACS), Acute Exacerbation of COPD
Studies at this site
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised — Recruiting now
- A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) — Recruiting now
- Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
- Evaluating the Communication Between Patients and Providers in Cancer Clinics — Recruiting now
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
- A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
- A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
- Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
- A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC — Recruiting now
- A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Recruiting now
- Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males — Recruiting now
- A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer — Recruiting now
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
- A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta — Recruiting now
- A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma — Recruiting now
- A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo — Recruiting now
- RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis — Recruiting now
- A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer — Recruiting now
- A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer — Recruiting now
- EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma — Recruiting now
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
- Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1 — Recruiting now
- Ocrevus Zunovo for MS: Mixed Methods — Recruiting now
- VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3] — Recruiting now
- Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor — Recruiting now
- Colonoscopy vs Stool Testing for Older Adults With Colon Polyps — Recruiting now
- Patient Retrospective Outcomes (PRO) — Recruiting now
- An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib — Recruiting now
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
- Cephea Early Feasibility Study — Recruiting now
- 4D-710 in Adult Patients With Cystic Fibrosis — Recruiting now
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
- BoxX-NoAF Clinical Trial — Recruiting now
- Watchful Waiting Versus Immediate Repair for Occult Contralateral Inguinal Hernias. — Recruiting now
- Abbott Cephea Mitral Valve Disease Registry — Recruiting now
- A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types — Recruiting now
- J-Tip Use for Paracentesis in Adults With Ascites — Recruiting now
- Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation — Recruiting now
- Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
- Proteogenomic Monitoring and Assessment of Liver Transplant Recipients — Recruiting now
- Transdermal Compress IDE Study — Recruiting now
- Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients — Recruiting now
- Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) — Recruiting now
- Comparing Efficiency and Stone-Free Rates Mini PCNL vs Flex URS — Recruiting now
- Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
- REgulatory T Cell Therapy to Achieve Immunosuppression REduction — Recruiting now
- A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer — Recruiting now
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
- CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) — Recruiting now